Announcements Trials

Browse Landscape

Phase

Phase 2 7 Phase 3 3 Phase 1/2 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 5 Breast Neoplasms 5 Small Cell Lung Carcinoma 3 Thoracic Neoplasms 2 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Lung Diseases 2 Carcinoma, Large Cell 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Retinoblastoma 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non-small Cell Lung Cancer Metastatic 1 Non-Small Cell Lung Cancer Metastatic 1 Neoplasms, Second Primary 1 Neoplasms by Site 1 Nasopharyngeal Neoplasms 1 NSCLC 1 Medulloblastoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Bronchogenic 1 Carcinoma 1 Cancer Therapy-related Cardiovascular Toxicity 1 Bronchial Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

icotinib 2 anlotinib 2 Drug Therapy 2 lorlatinib 1 Thalidomide 1 Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × NSCLC × Carboplatin × Clear all

NCT03799601 2019-01-10

ALTER-L013

Tongji Hospital

Phase 4 Unknown

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡